Aavanti Bio

Answer: AavantiBio's phone number is 35********

Answer: AavantiBio's official website is https://aavantibio.com

Answer: AavantiBio's revenue is $25 Million to $50 Million

Answer: AavantiBio's SIC: 8731

Answer: AavantiBio has 51-200 employees

Answer: AavantiBio is in Biotechnology

Answer: AavantiBio contact info: Phone number: 35******** Website: https://aavantibio.com

Answer: AavantiBio is a gene therapy company backed by a premier syndicate of life sciences investors including Perceptive Advisors, Bain Capital Life Sciences, and RA Capital Management, who led the companys $107 million Series A financing. Headquartered in Cambridge, Massachusetts, AavantiBios platform is focused on advancing innovative gene therapies in areas of high unmet medical need, including a lead program in Friedreichs Ataxia, a rare inherited genetic disease that causes cardiac and central nervous system dysfunction. The company benefits from strategic partnerships with the University of Floridas renowned Powell Gene Therapy Center and the MDA Care Center at UF Health where AavantiBios co-founders and renowned gene therapy researchers Barry Byrne, M.D., Ph.D. and Manuela Corti, P.T., Ph.D. maintain their research and clinical practices. We are looking for exceptional individuals who share our passion for developing novel therapies to treat rare diseases and advancing the field of gene transfer therapy. Developing genetic treatments for rare diseases is inspiring but challenging work and it takes dedication and courage which will make a meaningful impact on those who suffer from rare diseases. At AavantiBio, we will push each other to perform at our very best, and build a company that not only our employees are proud of, but also the rare disease community, because everyone knows we are trying to make a difference in patients lives. Come join our team!

Answer:

• LinkedIn